RAKESH GUPTA MD. Scope of the Problem History, Current Evidence and AHA Recommendations Physiology of Cardiac Arrest Complications of Return of Spontaneous

Embed Size (px)

Citation preview

  • Slide 1
  • RAKESH GUPTA MD
  • Slide 2
  • Scope of the Problem History, Current Evidence and AHA Recommendations Physiology of Cardiac Arrest Complications of Return of Spontaneous Circulation (ROSC) Pathophysiology and complications of Hypothermia Practical Aspects of Cooling
  • Slide 3
  • Slide 4
  • Sudden cardiac arrest (SCA) is a leading cause of death in the US Approximately 330,000 deaths annually in ED and out of hospital from SCA 80% or more of initially comatose survivors will then die or suffer debilitating neurologic outcomes AHA
  • Slide 5
  • Of patients arresting out-of-hospital, 3.0% received bystander cardiopulmonary resuscitation 9.1% had some prehospital CPR, 13.6% had ventricular fibrillation (VF) on ED arrival. In the witnessed arrests (80%), the estimated interval from arrest to initiation of CPR was 21.1 14.7 min. Survival to hospital discharge from out-of-hospital arrest was 5.1% for adults and 7.4% for children; All had poor neurologic outcome. For patients arresting in the ED, an initial rhythm of ventricular tachycardia (VT) or VF was strongly correlated with survival. Survival from ED arrest was 30.4% in adults, 42.9% in children; all but one had normal neurologic outcome. Cardiac arrest in Saudi Arabia: a 7-year experience in Riyadh Volume 17, Issue 4, Pages 617-623 (July 1999)
  • Slide 6
  • With n=19, survival was 6 of 12 in the cooled group and 1 of 7 without cooling with a target temperature of 31-32C.
  • Slide 7
  • 1961
  • Slide 8
  • 1980s Cardiac Arrest with Dogs
  • Slide 9
  • 2002s
  • Slide 10
  • Can we safely cool patients? What is the best method? Evidence for therapeutic hypothermia has lacked sufficient weight and the advisory panel support that thereby follows to propel it into common practice.
  • Slide 11
  • 77 patients 43 hypothermia 34 normothermia Results 49% of hypothermia - good outcome compared to 26% of normothermia (p=0.046) Bernard SA, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. NEJM 2002; 346 (8): 546-556.
  • Slide 12
  • 5 Levels 1. Good 2. Moderate 3. Severe 4. Coma, Vegetative State 5. Death The Brain Resuscitation Clinical Trial II Study Group, Control Clin Trials 1991 Aug; 12 (4): 525-545
  • Slide 13
  • Multi -Center Trial 275 patients 137 Hypothermia 138 Normothermia Results 55% Hypothermia group favorable outcome 39% Normothermia group favorable outcome (p=0.009) The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. NEJM 2002; 346 (8): 549-556.
  • Slide 14
  • Bernard et al. Resuscitation 2003: 22 post cardiac arrest, comatose adults 30ml/kg LR at 4 C infused over 30 min via peripheral IV then temp maintained at 33C Median temp decreased 1.6C after bolus (P=
  • Inclusion criteria Intubated patients with treatment initiated within a 6- hour post cardiac arrest (nonperfusing ventricular tachycardia [VT] or VF) Return of Spontaneous Circulation (ROSC) within 60 minutes of cardiac arrest Those able to maintain a systolic blood pressure >90 mm Hg, with or without pressors, after cardiopulmonary resuscitation (CPR) Those in a coma at the time of cooling. Brainstem reflexes and pathological/posturing movements +/- Patients with a Glasgow Coma Score (GCS) of 3 are eligible for hypothermia.
  • Slide 36
  • Exclusion criteria Recent major surgery within 14 days - Hypothermia may increase the risk of infection and bleeding. Systemic infection/sepsis - Hypothermia may inhibit immune function and is associated with a small increase in risk of infection. Patients in a coma from other causes (drug intoxication, preexisting coma prior to arrest) Patients with a known bleeding diathesis or with active ongoing bleeding - Hypothermia may impair the clotting system. Check prothrombin time/partial thromboplastin time (PT/PTT), fibrinogen value, and D-dimer value at admission. (Note: Patients may receive chemical thrombolysis, antiplatelet agents, or anticoagulants if deemed necessary in the treatment of the primary cardiac condition.) Patients with a valid do not resuscitate order (DNR)
  • Slide 37
  • Induction Quick Maintenance 24 hours Re-warming 8 hours
  • Slide 38
  • Slide 39
  • Ice bags Fans Intravenous Cooling Mechanical Cooling Endovascular Cooling
  • Slide 40
  • Intravenous cooling Mechanical or endovascular cooling Ice bags during induction
  • Slide 41
  • Bladder Rectal PA Catheter Esophageal Tympanic Axilla Monitor every 15 minutes during induction until stabilized at goal temperature 32-34C Avoid temperature